GLOBOCAN ALL CANCERS
NEWS & EVENTS
Stay ahead of the curve with Biosysion’s curated selection of news and events in the dynamic fields of molecular diagnostics and early cancer detection. From groundbreaking research to cutting-edge technologies, our news and events section keep you informed and engaged with the latest developments shaping the future of healthcare.
Discover the most recent breakthroughs and advancements in molecular diagnostics and cancer early detection. Our news section features updates on innovative diagnostic tests, novel biomarkers, and pioneering research findings from leading institutions around the world. Stay informed about the latest developments driving progress in the fight against cancer.
Scientific Evidence & Global Guidelines
American Cancer Society (ACS)
Relevance: General population screening guidance with strong FIT recommendation.
Source: Cancer.org
Visit Source →US Preventive Services Task Force (USPSTF)
Relevance: FIT / HS-gFOBT recommended as annual stool-based screening methods.
Source: USPSTF
Visit Source →US Multi-Society Task Force (USMSTF)
Relevance: FIT + colonoscopy listed as first-tier screening options with defined intervals.
Source: PubMed
Visit Source →ASGE — FIT Review
Relevance: Superior sensitivity and technical advantages over guaiac FOBT.
Source: ASGE.org
Visit Source →MDPI (2024) — CRC Screening Review
Relevance: Detailed evaluation of stool-based screening tests including FIT.
Source: MDPI
Visit Source →JAMA Network (2024)
Relevance: Real-world data showing reduced CRC mortality with routine FIT testing.
Source: JAMA Network
Visit Source →International Guidelines Supporting FIT Screening
🌍 World Health Organization (WHO)
Supports: Population-based CRC screening using FIT/FOBT.
Recognizes FIT as an effective non-invasive public-health screening tool.
🇺🇸 NCCN (USA)
Recommends: FIT annually for average-risk adults ≥45 years.
Positive FIT → colonoscopy. FIT recognized as evidence-based & cost-effective.
🇪🇺 ESGE (Europe)
Endorses: FIT for large-scale CRC screening; preferred over guaiac FOBT.
Supports centralized population FIT programs.
🇬🇧 NICE (United Kingdom)
Recommends: FIT for symptomatic patients in primary care.
Used for triage and colonoscopy referral prioritization.
🇮🇳 ICMR / MoHFW (India)
Position: FIT advised for community-level & population-based screening programs.
Recognizes need for scalable, low-cost CRC screening solutions.